Previous close | 14.30 |
Open | 14.30 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 220.00 |
Expiry date | 2025-02-21 |
Day's range | 14.30 - 14.30 |
Contract range | N/A |
Volume | |
Open interest | 25 |
Charles River and Lundbeck sign an agreement to use Logica to advance the discovery of novel neurological drugs.
WILMINGTON, Mass., October 03, 2024--Charles River previews SfN 2024, including the latest developments in CNS research and innovative approaches to tackling neurodegenerative disorders.
WILMINGTON, Mass., October 02, 2024--Charles River and Lundbeck enter agreement to utilize AI-powered Logica to advance the discovery of novel drugs for neurological disease.